Append Medical — raw details

Highlights

1 patentProfile claimed by owner

About

Trans-septal Left Atrial Appendage Closure Device

Append Medical has developed a minimally invasive implantable device designed to reduce stroke risk in patients suffering from atrial fibrillation. The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA closure thus reducing the risk of stroke in patients with non-valvular atrial fibrillation. Its unique design may allow it to mitigate device-related thromboembolism risk by leaving minimal foreign material at the closure site.

The Left Atrial Appendage exclusion technology was invented by Dr. Leonid Sternik and developed at Sheba Medical Center, further licensed by Append Medical. The company is a portfolio company of MEDX Xelerator.

Identity

Name	Append Medical
Slug	append-medical
Type / kind	startup
Crunchbase ID	append-medical
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIPk7Y4LDA

Status

Status	active
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Or Yehuda
HQ address	Ariel Sharon Boulevard 8, Or Yehuda, Israel

Web & social

Website	https://appendmedical.com
LinkedIn	https://www.linkedin.com/company/30743186
Twitter / X	https://twitter.com/appendmedical

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Technologies

Materials & SubstancesImplants

Target customers

Healthcare & Life SciencesHealthcareProviders

Business models

B2B

Funding

Total raised	$12.6M
Current stage	Series A

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}